| Product Code: ETC7739390 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan HER2 Positive Breast Cancer Treatment Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Japan HER2 Positive Breast Cancer Treatment Market - Industry Life Cycle |
3.4 Japan HER2 Positive Breast Cancer Treatment Market - Porter's Five Forces |
3.5 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan HER2 Positive Breast Cancer Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HER2 positive breast cancer in Japan |
4.2.2 Rising awareness about advanced treatment options for HER2 positive breast cancer |
4.2.3 Technological advancements in targeted therapies for HER2 positive breast cancer |
4.3 Market Restraints |
4.3.1 High cost of HER2 targeted therapies |
4.3.2 Stringent regulatory requirements for approval of new treatments |
4.3.3 Limited access to specialized healthcare facilities in rural areas of Japan |
5 Japan HER2 Positive Breast Cancer Treatment Market Trends |
6 Japan HER2 Positive Breast Cancer Treatment Market, By Types |
6.1 Japan HER2 Positive Breast Cancer Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.4 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.6 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan HER2 Positive Breast Cancer Treatment Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 Japan HER2 Positive Breast Cancer Treatment Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.3.5 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan HER2 Positive Breast Cancer Treatment Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Japan HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Japan HER2 Positive Breast Cancer Treatment Market Import-Export Trade Statistics |
7.1 Japan HER2 Positive Breast Cancer Treatment Market Export to Major Countries |
7.2 Japan HER2 Positive Breast Cancer Treatment Market Imports from Major Countries |
8 Japan HER2 Positive Breast Cancer Treatment Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rate of HER2 targeted therapies in Japan |
8.3 Number of clinical trials for HER2 positive breast cancer treatments in the country |
9 Japan HER2 Positive Breast Cancer Treatment Market - Opportunity Assessment |
9.1 Japan HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Japan HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Japan HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Japan HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan HER2 Positive Breast Cancer Treatment Market - Competitive Landscape |
10.1 Japan HER2 Positive Breast Cancer Treatment Market Revenue Share, By Companies, 2024 |
10.2 Japan HER2 Positive Breast Cancer Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here